Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Innovation Tri-Valley Leadership Group Calls Regional Community into Action

“It’s great to see the Tri-Valley leverage its awesome power as an innovation hub, as well as its leadership and generosity, to help our communities weather this terrible storm,” Congressman Eric Swalwell said. “We are stronger together than apart, and together we will get through this.”

Tri-Valley companies are flattening the curve and fighting the pandemic that is affecting us all on a global scale.

#TRIVALLEYtogether highlights some of the region’s most immediate needs and calls on the broad business community and public to take action. With increased global shortages of supplies, Tri-Valley health care providers and educators are gratefully accepting donations of needed supplies from the community. CLICK HERE for more information.

“It’s great to see the Tri-Valley leverage its awesome power as an innovation hub, as well as its leadership and generosity, to help our communities weather this terrible storm,” Congressman Eric Swalwell said. “We are stronger together than apart, and together we will get through this.”

The Tri-Valley’s technology assets are the engine for the region’s economic strength. Lawrence Livermore National Laboratory, Sandia National Laboratories, several regional hospitals and dozens of life science companies like Roche Molecular Solutions and DeltaTrak are generating innovations to battle the virus every day.

“#TRIVALLEYtogether targets 3 sectors that need our support right away,” said Steve Lanza, Vice President of Lam Research and Chair of Innovation Tri-Valley Leadership Group (ITV). “With so many in need, we are hopeful everyone can find a way to contribute. We are calling on our innovative community of thinkers and doers in the Tri-Valley to step up right now to make a huge impact together. Given the diversity of need, we are encouraging those who can to find a path to help.” ITV welcomes businesses all across the San Francisco East Bay region to join this effort using innovation, empathy and connectivity to build regional resiliency.

#TRIVALLEYtogether invites donations of technology to support online learning, medical supplies to TRIVALLEY Hospitals and medical centers, and cash to support the region’s most vulnerable homeless population. CLICK HERE for more information.

Join Innovation TRIVALLEY Leadership Group (ITV) by spreading the word, donating, or simply supporting your local businesses as we navigate this time of uncertainly together. CLICK HERE for more information to find your way to help.


For Volunteer and Donation Opportunities in your local TRIVALLEY community:

Town of Danville – For Town resources CLICK HERE

Danville Chamber Updates CLICK HERE

City of Dublin – For information on City resources CLICK HERE

City of Dublin Resource Guide CLICK HERE

City of Livermore – For information on City resources CLICK HERE

Unify Livermore Community Support Information CLICK HERE

Livermore Chamber Updates CLICK HERE

City of Pleasanton – For information on City resources CLICK HERE

Pleasanton Donation Information CLICK HERE

City of San Ramon – For information on City resources CLICK HERE

Contra Costa Community Donation Information CLICK HERE

ABOUT Innovation Tri-Valley Leadership Group

Innovation Tri-Valley Leadership Group (ITV) is a collective of leaders and influencers committed to connecting the businesses, educational institutions, research labs, and civic leaders in the Tri-Valley region. ITV showcases the region as a technology and innovation powerhouse, outpacing the Bay Area mega-region in both job creation and economic growth. The Tri-Valley today is home to more than 450 technology companies and the regional innovation economy drives a $42 billion GDP.

Share article on social media or email:

Water utilities taking steps to prevent disruptions, assist households, according to new AWWA survey

With water and wastewater critical to fighting the coronavirus (COVID-19) pandemic, water utilities are swiftly employing plans to prevent service disruptions and assist households struggling to pay water bills, according to a recent survey conducted by the American Water Works Association (AWWA).

Ninety-seven percent of the 532 responding utilities have measures in place or in development to keep essential field workers on the job. Ninety-five percent of the responses indicate they are assessing options for staff shift change policies to incorporate social distancing at the workplace.

The two most pressing challenges reported by utilities are social distancing of workforce and supply chain issues for personal protective equipment (PPE). Nearly 40 percent of utilities reported disruptions in the supply chain for PPE, and nearly three quarters are expecting disruptions in the future.

Conducted online from March 25-30, this marks the second in a series of surveys of how AWWA member organizations are adapting to impacts from the COVID-19 pandemic. The second survey of AWWA member organizations generated 615 responses, including from 532 different utilities and 81 non-utility responses (consultants, manufacturers, service providers and others). The responses offer a near real-time assessment of how water sector organizations are currently managing risks of the COVID-19 pandemic.

To assist customers impacted by the economic fallout of COVID-19, more than 90 percent of responding utilities have suspended water shut-offs and about 67 percent are waiving late fees. Additionally, some utilities indicate they are providing payment plan options, waiving charges like service fees, and a few are considering rate reductions or forgiving payments for one billing cycle.

The survey also showed utilities are concerned about potential revenue challenges, with 64 percent of utilities expecting financial implications in the coming months and about 10 percent are already seeing revenue reductions. AWWA and other water sector organizations are advocating for the inclusion of water sector funding in future stimulus bills.

Sixty-seven percent of utilities reported that they have business continuity plans in place, and another 20 percent are currently developing them. AWWA is encouraging utilities to take advantage of Business Continuity Planning for Water Utilities: Guidance Document (AWWA, Water Research Foundation, U.S. EPA, 2013) in assessing their plans.

AWWA is offering resources to assist utilities with dealing with the challenges that arise during the pandemic at

Established in 1881, the American Water Works Association is the largest nonprofit, scientific and educational association dedicated to managing and treating water, the world’s most important resource. With approximately 51,000 members, AWWA provides solutions to improve public health, protect the environment, strengthen the economy and enhance our quality of life.

Share article on social media or email:

West Boca Eye Center Adapts to COVID-19 Pandemic Protocols to Safely Provide Urgent & Emergent Care

The Coronavirus pandemic means health care providers are adopting radical precautions while treating patients. In accordance with the CDC and WHO, the West Boca Eye Center has ceased all procedures except those of an urgent or emergency nature.

West Boca Eye Center Adapts to COVID-19 Pandemic Protocols to Safely Provide Urgent & Emergent Care

The Coronavirus pandemic means health care providers are adopting radical precautions while treating patients. In accordance with the CDC and WHO, the West Boca Eye Center has ceased all procedures except those of an urgent or emergency nature. Brent Bellotte MD. explains how they’re providing for the welfare of patients and staff alike.

The provision of impeccable infection control is something the West Boca Eye Center prides themselves upon at all times. Never has this been more crucial than right now, and one of the biggest issues for the ophthalmology industry is that it involves up-close work with an area of the body that presents a high-risk portal of entry for the virus to infect the body—the eyes.

Following in-depth collaborations with major subspecialty societies, lead clinician at the clinic, Brent Bellotte MD. has put in place strict guidelines regarding treatment provided to their patients. This has been done to ensure the safety of both staff and patients in this time of unprecedented risk.

COVID-19 Specific Precautions in Place at the West Boca Eye Center

With immediate effect, the clinic has ceased the provision of all ophthalmology care that doesn’t fall into emergency or urgent categories. Initial consultations will take place via telephone and/or video consultation. Following this, those deemed in need of urgent or emergency attention will be asked a range of questions to determine their risk of having been exposed to the virus. These include, but aren’t limited to, asking about any of the common symptoms of COVID-19—fever, cough, or other respiratory issues—as well as recent travel (in the past 14 days) to a country or US region with high numbers of infected cases.

Should the patient answer yes to one or more of these they will immediately be directed to their primary care physician. Patients deemed appropriate for treatment within the clinic will be invited for an appointment. Social distancing of at least 6 feet will be strictly adhered to, with patients requested not to arrive before their allotted appointment time to ensure the waiting area is kept as clear as possible. Those who’ve been determined as the most vulnerable due to age and/or health conditions will only be requested to attend the clinic if absolutely necessary.

Safety during individual treatment

All areas and equipment will be thoroughly cleaned and disinfected between each patient to reduce contamination risk as much as possible. When invited to enter the treatment room patients will be requested to speak as little as possible during the procedure—a practice that the clinician will also adhere to. Anyone who is coughing, sneezing, or has any flu-like symptoms will be requested to wear a mask during their eye examination. Breath shields and slit-lamp barriers may also be in place to further shield against infection.

Any patients with respiratory illness symptoms but without any COVID-19 risk factors will be treated by a clinician wearing gloves, gowns, surgical masks, and eye protection. The clinician may wear an N-95 mask should the treatment necessitate. The examination room will be thoroughly disinfected after each patient.

As always, the safety of the patients and staff is of the utmost priority. With the pandemic presenting an evolving situation, Brent Bellotte MD. and his clinical team are in constant communication with the CDC, WHO, and the American Board of Ophthalmology to ensure the West Boca Eye Centre adheres to the very latest safety standards.

Anyone requiring urgent treatment or advice on their eye condition or ongoing care is requested to make contact by phone or email in the first instance. Further details about the clinic can be found at

Share article on social media or email:

pdfFiller Offers 3 Free Months of Their HIPAA Compliant Paperless Workflow Solution to All US-Based Healthcare Institutions

News Image

Over 40,000 healthcare professionals are already using the HIPAA compliant pdfFiller platform to aid in their paperless document transactions. “Hospitals, clinics and pharmacies are finding pdfFiller to be an irreplaceable solution due to its ease of use on phones and tablets for handling a variety of forms and documents including patient intake forms, release forms and patient history forms. Larger clinics also use pdfFiller to host fillable forms directly on their sites to speed up processes like remote registration as well as scheduling appointments and requests”, explains Borya Shakhonovich, CEO of airSlate — parent company of pdfFiller.

“Simply saying “thank you” to all the healthcare workers who are risking their lives on the frontline these days is not enough. We would like to offer practical help. That’s why we’re providing 3 free months of our Premium subscription to all medical and other healthcare-related organizations to automate their document workflows: increasing social distancing while servicing more patients and building safe working environments for healthcare administrative staff.”

PDFfiller assists with:

  • Authoring and automating patient forms
  • Adding fillable and e-signature fields
  • Supplying online fillable forms and an e-signature tool that is HIPAA compliant
  • Mobile accessibility for phones and tablets
  • A simple interface that requires no training and is used by millions
  • Secure record-keeping for all data

“We can’t save lives but we can do our small part in containing the pandemic by offering what we are best known for — a convenient form-filler, easy e-signing and secure online storage for sensitive data.” — Borya Shakhnovich, CEO of airSlate — parent company of pdfFiller.

If you’re working in healthcare, fill out this short form and our Support agents will set up a free pdfFiller Premium account for you.

About pdfFiller:

pdfFiller has been providing its 20 million users with an all-in-one online PDF editor, e-signature and form builder since 2008. pdfFiller’s web-based solution is seamlessly integrated with Salesforce, Microsoft Dynamics 365, Google Suite and more. The pdfFiller mobile app is available on iOS and Android.

Share article on social media or email:

Lavi Industries Announces New Products for Safe Social Distancing While Queuing

Qtrac Smartphone Queuing

“Businesses are faced with an immediate need to implement new, safer queuing strategies. The lead time from decision to installation needs to be quick, allowing businesses the opportunity to get back to serving their customers and keeping them safe” – Perry Kuklin, Director of Marketing

The month of March saw a dramatic shift in the way businesses serve their customers. Concerns over Coronavirus (COVID-19), has led to an increased focus on customer safety and health, creating new queuing challenges for restaurants, grocery stores, retailers, laboratories, pharmacies, medical centers and others. How businesses and customers physically interact with each other has rarely been more important than it is in this time of abrupt change.

Lavi Industries is familiar with adapting to new and sudden changes in queuing, with over 40 years of assisting the TSA and countless other agencies and organizations with queuing strategies, products and services. “Businesses are faced with an immediate need to implement new, safer queuing strategies. The lead time from decision to installation needs to be quick, allowing businesses the opportunity to get back to serving their customers and keeping them safe” says Perry Kuklin, Director of Marketing for Lavi Industries. “We want to help, and one way we can do that is to look at the products and services we offer and find a way to make them even more accessible and useful”.

One such service is Lavi’s new smartphone queuing technology. “We have been offering virtual queuing through our Qtrac VR product for several years now, and we know the benefits it provides our customers,” states Kuklin. “It enables contactless engagement, allows the customer to wait outside the business premisis or in the safety of their car, and provides the business a way to control customer access into the building or space.”The lead time for implementaton of our standard Qtrac VR would average 2-3 weeks due to all of the customization options. However, we knew our customers needed something sooner than that”, Kuklin explains, “so we asked our team to create a simpler solution that could be implemented immediately”. The result was Qtrac VR Smartphone Queuing. With no app or hardware to install, businesses are able to begin using the program within days. “We’ve recently implemented this program into 300 branches at a financial institution in just 5 days. Smaller implementations take just a day,” states Kuklin. Customers simply scan a QR code using their smartphone camera or text their name. They are then automatically directed to a webpage where they can track their place in line, ask for more time, or communicate with staff if necessary. The webpage, or a text message, then alerts the customer when it is their turn for service.

“It’s the safest solution for providing social distancing to your customers, with the added benefit of being quick and easy to use and implement,” says Kuklin. “However, we know there are some businesses that may still require a physical queue, and we wanted to make sure we helped them as well”. Seeing the lines of customers outside grocery stores was enough inspiration to realize what needed to happen. “People are not used to social distancing yet, and don’t always recognize six feet of safe distance without visual cues,” says Kuklin. “Our portable retractable belt stanchions not only help organize queues and help keep waiting customers safe, but they also happen to have 7’ long retractable belts – perfect for identifying safe social distance.” Lavi Industries has designed and begun selling stanchions with a new custom belt, printed with visual cues to help customers maintain a minimum six feet of safe space between them. In addition, stanchion signs have been designed to help reinforce safe social distance practices. The signage and custom belts are easily installed on any of the retractable belt stanchions offered by Lavi Industries, and take only a few minutes to install and set-up.

About Lavi Industries

Based in Valencia, California, Lavi Industries is the premier provider of public guidance and crowd control solutions in the Americas. Leveraging its portfolio of world-class brands – Beltrac® stanchions, Directrac® signage systems, Qtrac® electronic queuing systems, and NeXtrac® in-queue merchandising systems – Lavi has helped the world’s leading companies effectively guide people in, through, and out of their facilities. More information is available at

Share article on social media or email:

RED Company Taps Life Sciences and Healthcare Industry Relationships to Deliver Supplies to Those in Need

News Image

Carmela Roth

It is my passion to deliver a high-touch approach, creative cost savings, flexibility and tenacity to each customer. This is more important than ever, especially given our service-centric company culture in this very difficult time.

Today RED Company founder and President, Carmela Roth, announced the launch of her sourcing website to support businesses looking to quickly source healthcare supplies. Due to her long-standing relationships within the life sciences and healthcare industry, RED Company has been sourcing goods internationally and making them available to U.S. businesses in a seamless manner for years through its division known as RED Swag.    

“We’ve been supplying hand sanitizer, wet wipes, first aid kits and disaster prepaRED kits to companies for years. We have international and domestic suppliers ready to tap into. It is my passion to deliver a high-touch approach, creative cost savings, flexibility and tenacity to each customer. This is more important than ever, especially given our service-centric company culture in this very difficult time,” said Roth.

In addition to the WFH kits, WOFH (work out from home) kits, stay well kits and traditional healthcare items Roth has been selling via RED Swag, the new site will also carry:

  • Masks and Face Shields
  • Hand Sanitizer
  • Shoe Covers
  • Isolation Gowns

The website,, will serve to support those public and private sector entities looking to source health gear more efficiently.

About Carmela Roth

As RED Company’s founder and President, Carmela Roth brings over 30 years of experience and dedication in meeting planning, special event production, sourcing and logistics.

In 2017, Roth was named to the Board of Directors for Diversity Alliance for Science, a platform to identify, attract and develop small and/or diverse businesses to drive inclusive procurement practices in corporate, academic and governmental entities within the life science and healthcare industries. RED Company has been recognized as one of the LA Business Journal’s Top 100 Women-Owned Businesses for the last seven years and their Top 100 Fastest Growing Companies for three. In 2016, RED Company earned recognition in Inc. 500’s 5000 Fastest Growing Private Companies in the US.

RED Company’s service-centric culture and desire to give back is marked through its Power-full Acts of Compassion and Kindness™ initiatives through their recently launched RED PACK™ Program.

To interview or collaborate with Roth, please email or

Share article on social media or email:

RSNA Publishes Fleischner Society Statement on Chest Imaging and COVID-19

A multinational consensus statement from the Fleischner Society on the role of chest imaging in the management of patients with COVID-19 was jointly published today in the journals Radiology and Chest.

“We need to understand that conditions across the globe vary greatly. Our goal in developing this statement was to offer guidance that is sensitive to these differences and applicable broadly,” said Geoffrey D. Rubin, M.D., George B. Geller Professor of Cardiovascular Research, professor of radiology and bioengineering at Duke University School of Medicine in Durham, North Carolina.

The statement represents the collective opinions and perspectives of thoracic radiology, pulmonology, intensive care, emergency medicine, laboratory medicine and infection control experts practicing in 10 countries, representative of the highest burden of COVID-19 worldwide.

“The willingness of experts from around the world to pause from their care of patients to contribute their knowledge and experience toward this international consensus was inspiring,” Dr. Rubin said.

Chest CT and X-ray are key tools in the diagnosis and management of numerous respiratory ailments, but their role in the management of COVID-19 has not been considered within the context of many variables, including the severity of respiratory disease, pre-test probability, risk factors for disease progression, and critical resource constraints.

“The Fleischner statement was uniquely comprised of a multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments,” said Radiology Editor David A. Bluemke, M.D.

The panel evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions and resource constraints.

Fourteen key questions, corresponding to 11 decision points within the three scenarios and three additional clinical situations, were rated by the panel based upon the anticipated value of the information that thoracic imaging would be expected to provide. The results were aggregated, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of chest X-ray and CT in the management of COVID-19.

The results suggested that imaging is not routinely indicated in asymptomatic individuals or patients with suspected COVID-19 and mild clinical symptoms. Use of chest imaging is indicated in patients with COVID-19 who have worsening respiratory status. Imaging is also indicated for patients with moderate to severe features of COVID-19 regardless of COVID-19 test results.

In a resource-constrained environment (lack of personal protection equipment or availability of COVID-19 testing), imaging is indicated for medical triage of patients with suspected COVID-19 who present with moderate to severe clinical features and a high pre-test probability of disease.

The panel also found that CT is appropriate in patients with functional impairment and/or hypoxemia (low level of oxygen in the blood) after recovery from COVID-19. When there is known community transmission, evidence of COVID-19 has been incidentally found on CT scans. In these cases, patients should have COVID-19 testing using a reverse-transcription polymerase chain reaction (RT-PCR) viral assay.

The authors note that this consensus statement represents opinion at a moment in time within a highly dynamic environment where the status of regional epidemics and the availability of critical resources to combat those epidemics vary daily. Recommendations may undergo refinement as the situation evolves.

“Currently, no therapy has been confirmed to alter the course of COVID-19, there is no known cure, and there is no vaccine for prevention,” Dr. Rubin said. “As effective treatments are developed, thoracic imaging may find new roles by establishing treatment response or characterizing patients as likely responders to novel therapies.”

RSNA is committed to connecting radiologists and the radiology community to the most timely and useful COVID-19 information and resources. RSNA’s COVID-19 Resources page houses the latest guidance, original research, image collection and more. The page will be updated on an ongoing basis.

An associated special edition podcast from Dr. Bluemke is available.

“The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.” Geoffrey D. Rubin, Christopher J. Ryerson, Linda B. Haramati, Nicola Sverzellati, Jeffrey P. Kanne, Suhail Raoof, Neil W. Schluger, Annalisa Volpi, Jae-Joon Yim, Ian B. K. Martin, Deverick J. Anderson, Christina Kong, Talissa Altes, Andrew Bush, Sujal R. Desai, Jonathan Goldin, Jin Mo Goo, Marc Humbert, Yoshikazu Inoue, Hans-Ulrich Kauczor, Fengming Luo, Peter J. Mazzone, Mathias Prokop, Martine Remy-Jardin, Luca Richeldi, Cornelia M. Schaefer-Prokop, Noriyuki Tomiyama, Athol U. Wells and Ann N. Leung.

Radiology is edited by David A. Bluemke, M.D., Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, and owned and published by the Radiological Society of North America, Inc. (

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (

The Fleischner Society is an international, multidisciplinary medical society for thoracic radiology, dedicated to the diagnosis and treatment of diseases of the chest. (

For patient-friendly information on chest imaging, visit

Ziegler Advises Physician Housecalls On Its Investment By Council Capital

Chris Hendrickson, Managing Director in Ziegler’s Healthcare Corporate Finance practice stated, “Hank and Cindy have demonstrated the ability to rapidly expand into new markets while adding providers and integrating practices operationally…”

Ziegler, a specialty investment bank, is pleased to announce its role in advising Physician Housecalls (PHC) on its investment by Council Capital (Council). PHC is the leading provider of home-based primary care in Oklahoma and Kansas, and is rapidly expanding its current footprint in surrounding states. PHC will use this investment to fund its expansion as well as gain access to Council’s sophisticated CEO Council Model, which has demonstrated considerable success driving growth for emerging growth healthcare companies.

Founded in 2012, PHC provides convenient access to the care needs of homebound patients focusing primarily on those within the Medicare population with two or more chronic diseases that have difficulty leaving their home. PHC deploys physicians, nurse practitioners and physician assistants with primary care experience to the home and via telehealth. PHC has recently expanded into Kansas through acquisition and has numerous expansion targets under LOI. Key themes within healthcare such as the drive to see patients within the lowest cost setting, the push to fee for value as well as specific programs such as Primary Care First – a five year Medicare demonstration that is driving significantly increased reimbursement across 26 regions, are key drivers that will enable PHC’s sustained growth.

PHC is led by CEO, Hank Ross, and VP Clinical Services, Cindy Longanacre, who were successful home health operators before starting PHC to address a critical need for homebound patients. Hank Ross stated, “Significant forces within healthcare are enabling the emergence of home based primary care.” Ross continued, “We want to expand our key learnings into new markets and Council Capital has unique executive-level resources that will help us expand our footprint and capabilities.”

Chris Hendrickson, Managing Director in Ziegler’s Healthcare Corporate Finance practice stated, “Hank and Cindy have demonstrated the ability to rapidly expand into new markets while adding providers and integrating practices operationally. Growth capital combined with Council Capital’s demonstrated expertise at growing companies will be critical in PHC’s next stage, as it looks to become a larger regional player and ultimately a national leader within home based primary care.”

Eric Keen, General Partner at Council Capital, commented, “Home based primary care is an investment theme we have been investigating for more than a year. PHC offers an innovative and effective service that greatly improves the patient’s quality of care and satisfaction, reduces costs to the healthcare system, and creates a more meaningful practice experience for providers. These attributes align strongly with our strategy of investing on the “right side of change in healthcare” – where we are able to grow and generate returns by investing into companies that improve the patient experience while also reducing cost.” Keen continued, “We are excited to be partnering with the management team at Physician Housecalls and look forward to supporting them in their current mission while also working to further develop and enhance the organization to drive further growth.”

Ziegler’s Corporate Finance team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals and senior living, Ziegler is one of the most active M&A firms offering innovative sell-side, buy-side, recapitalization/restructuring, equity private placement and strategic partnering services.

For more information about Ziegler, please visit us at

About Ziegler:

Ziegler is a privately held, national boutique investment bank, capital markets and proprietary

investments firm. It has a unique focus on healthcare, senior living and education sectors, as

well as general municipal and structured finance. Headquartered in Chicago with regional and

branch offices throughout the U.S., Ziegler provides its clients with capital raising, strategic advisory

services, fixed income sales, underwriting and trading as well as Ziegler Credit, Surveillance and Analytics. To learn more, visit

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

Share article on social media or email:

PTW Announces First North American Installation and FDA 510(k) Clearance of BEAMSCAN® MR Motorized 3D Water Phantom


PTW BEAMSCAN® MR for Elekta Unity at Princess Margaret Cancer Centre

The BEAMSCAN MR enables us to conduct in-depth radiation beam characterization and quality assurance of our Unity MR-LINAC. Because it is designed for compatibility with the Elekta Unity, we can perform accurate beam profile and depth-dose curve measurements in the specific geometry of the MR-LINAC.

PTW has installed the first BEAMSCAN® MR motorized 3D water phantom in North America at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. In addition, PTW announces that the BEAMSCAN MR water phantom recently received 510(k) clearance from the U.S. Food and Drug Administration and is now available for sale within the United States. The BEAMSCAN MR motorized 3D water phantom provides a dedicated, fully equipped solution for beam data commissioning and annual QA of MR-LINACs.

The Princess Margaret Cancer Centre is part of the University Health Network, which is affiliated with the University of Toronto. It is one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment facility in Canada. It houses two state-of-the-art MR-LINAC systems: an Elekta Unity system as well as an MR-on-rail system combined with a linear accelerator and a brachytherapy afterloader (MRgRT system).

“We invested in the BEAMSCAN MR because it is an essential tool for the commissioning and maintenance of our Elekta Unity MR-LINAC,” said Daniel Létourneau PhD, head of physics in the Radiation Medicine Program at Princess Margaret Cancer Centre. Dr. Létourneau leads clinical operations as well as the academic and education activities of the Medical Physics Department at the Princess Margaret Cancer Centre.

“The BEAMSCAN MR enables us to conduct in-depth radiation beam characterization and quality assurance of our Unity MR-LINAC,” Dr. Létourneau added. “Because it is designed for compatibility with the Elekta Unity, we can perform accurate beam profile and depth-dose curve measurements in the specific geometry of the MR-LINAC.”

The BEAMSCAN MR water phantom is available for both the Elekta Unity and ViewRay® MRIdian® MR-LINACs. It is the first motorized 3D water phantom suitable for clinical use in a 1.5 T MR environment. The BEAMSCAN MR phantom comes ready to use on a single carriage and includes everything needed for operation.

PTW is continuously developing innovative dosimetry solutions to deliver fast, precise measurements for complex radiation equipment and treatment plans. PTW delivers a full line of dosimetry solutions for acceptance testing, beam data commissioning, and machine- and patient-specific QA.

For more information about the BEAMSCAN MR motorized 3D water phantom, visit the MR-guided radiotherapy QA solutions product page on PTW’s website:

Find details about The Princess Margaret Cancer Centre here

About PTW

PTW is a world leader in high-precision dosimetry solutions. Founded in 1922, the company is a pioneer in medical radiation measurement. PTW owns one of the oldest and largest accredited calibration laboratories in the field of ionizing radiation and established THE DOSIMETRY SCHOOL to promote the exchange of knowledge in clinical dosimetry. PTW operates globally with nine international subsidiaries and more than 350 employees worldwide. For more information, visit:

Media Contact

Lisa Goetz

Schubert b2b

610-269-2100 x244

Share article on social media or email:

LifeDNA and University of Hawai’i Collaborate on Studying Why Certain Populations Are Hit Harder

Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA’s scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations.

LifeDNA, Inc., a pioneering personal genomics company, has initiated a coronavirus study aimed at understanding why certain individuals and racial/ethnic groups are more prone to the infection and may suffer a more severe course of COVID-19.

“COVID-19 has upended daily life for citizens around the globe,” said Cyril Moukarzel, CEO of LifeDNA, Inc. “Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA’s scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations.”

Honolulu-based LifeDNA is collaborating with molecular epidemiologist Maarit Tiirikainen, Ph.D., Associate Professor at the University of Hawai’i at Mānoa. The study will initially focus on the multi-ethnic population of Hawai‘i and genetic variants of the ACE2 gene as they relate to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

“There have been major differences in the rates of SARS-CoV-2 infection and the severe disease between the different geographic regions since the beginning of the COVID-19 pandemic, even among young individuals,” Dr. Tiirikainen said. “Epidemiological studies—so-called Genome Wide Association Studies (GWAS)—indicate that populations carry different variants of the ACE2 gene. This variation in the gene coding for the ACE2 receptor may have an effect on the number of ACE2 receptors on the lung cells, as well as on how effectively the virus binds to the receptor. There may also be genetic differences in immune and other important genes explaining why some people get more sick than others.”

For more than three years now, LifeDNA has been utilizing published GWAS data to provide reports on the association of genetic variants to various human traits. In this global health crisis, LifeDNA will focus its scientific resources on determining why certain individuals and ethnic populations seem more prone to the SARS-CoV-2 infection and may also have a more severe course of the COVID-19 disease. The differences in the severity of the disease may also have an effect on future lung cancer incidences in different populations, especially when augmented by smoking.

The genotyping for the study will be done at the Kaka’ako Genomics and Bioinformatics Shared Resource (co-directed by Dr. Tiirikainen) at the University of Hawai‘i Cancer Center.

LifeDNA expects that the findings of its study will allow for identifying the most vulnerable individuals and populations ahead of time in future SARS virus-family outbreaks. The company also envisions pharmacogenomics collaborations on life-enhancing and lifesaving preventive therapeutics, such as those utilizing CRISPR-Cas9 gene editing technology. While LifeDNA has yet to initiate formal partnership dialogue, companies with this relevant domain expertise include CRISPR Therapeutics AG, Editas Medicine, Inc. and Intellia Therapeutics, Inc.

About LifeDNA

LifeDNA is a leading personal genomics company headquartered in Honolulu. The company’s mission is to help people lead healthier and more fulfilling lives by unlocking the power of their unique DNA. LifeDNA’s offerings include a self-administered, cheek swab DNA test kit and reports on 137 traits in the following categories: health, personality, fitness, nutrition and skin. Consumers who have already taken a DNA test with 23andMe, Ancestry or MyHeritage may upload their DNA raw data files (DNA test results) to gain deeper insight with LifeDNA’s critically acclaimed reports. LifeDNA is headquartered in Honolulu and privately backed by Markowitz Trust and other investors. Learn more at Like LifeDNA on Facebook at Follow LifeDNA on Twitter @golifedna.

About the University of Hawai’i Cancer Center

The University of Hawai’i Cancer Center through its various activities, cancer trial patients and their guests, and other visitors adds more than $54 million to the O‘ahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawaiʻi at Mānoa, the Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawai’i and the Pacific. Learn more at Like UC Cancer Center on Facebook at Follow the UH Cancer Center on Twitter @UHCancerCenter.

Share article on social media or email: